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ARTICLE OPEN
Improving outcomes for people with COPD by developing
networks of general practices: evaluation of a quality
improvement project in east London
Sally Hull1, Rohini Mathur1, Simon Lloyd-Owen2, Thomas Round3 and John Robson1
BACKGROUND: Structured care for people with chronic obstructive pulmonary disease (COPD) can improve outcomes. Delivering
care in a deprived ethnically diverse area can prove challenging.
AIMS: Evaluation of a system change to enhance COPD care delivery in a primary care setting between 2010 and 2013 using
observational data.
METHODS: All 36 practices in one inner London primary care trust were grouped geographically into eight networks of
4–5 practices, each supported by a network manager, clerical staff and an educational budget. A multidisciplinary group, including
a respiratory specialist and the community respiratory team, developed a ‘care package’ for COPD management, with ﬁnancial
incentives based on network achievements of clinical targets and supported case management and education. Monthly electronic
dashboards enabled networks to track and improve performance.
RESULTS: The size of network COPD registers increased by 10% in the ﬁrst year. Between 2010 and 2013 completed care plans
increased from 53 to 86.5%, pulmonary rehabilitation referrals rose from 45 to 70% and rates of ﬂu immunisation from 81 to 83%,
exceeding London and England ﬁgures. Hospital admissions decreased in Tower Hamlets from a historic high base.
CONCLUSIONS: Investment of ﬁnancial, organisational and educational resource into general practice networks was associated
with clinically important improvements in COPD care in socially deprived, ethnically diverse communities. Key behaviour change
included the following: collaborative working between practices driven by high-quality information to support performance review;
shared ﬁnancial incentives; and engagement between primary and secondary care clinicians.
npj Primary Care Respiratory Medicine (2014) 24, 14082; doi:10.1038/npjpcrm.2014.82; published online 16 October 2014
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is the ﬁfth leading
cause of death in the UK. It accounts for 30,000 deaths a year,
1.4 million general practitioner (GP) consultations, and one in
eight emergency hospital admissions—and is therefore one of the
most costly inpatient conditions treated by the NHS, accounting
for nearly 10% of all bed days.1 The main cause of COPD is
tobacco smoking, but it is also associated with occupational
exposure,2 indoor air pollutants,3 alpha 1 antitrypsin deﬁciency4
and childhood respiratory infections.5,6 COPD is more prevalent in
men, older people and in deprived and urban populations.7
Using data from the Quality and Outcomes Framework (QOF),
the UK general practice pay for performance scheme,8 estimates
the UK COPD prevalence to be 1.4%, but epidemiological
studies suggest that the prevalence is considerably higher.
A cross-sectional study using Health Survey for England data
estimated the UK COPD prevalence to be 3.7% in 2005.9 Under-
diagnosis appears to be more prevalent in urban areas, particularly
in London.10
The majority of routine COPD management takes place in primary
care, with the most cost-effective interventions being smoking
cessation, ﬂu immunisation and pulmonary rehabilitation.11
Structured care, particularly the early treatment of disease
exacerbations, reduces morbidity and deterioration in the quality
of life.12,13 In contrast to other major chronic disorders, such as
diabetes, the evidence for promoting self-management, action
plans or case management remains weak, except among selected
subgroups of younger patients.14,15
Pulmonary rehabilitation is an effective intervention for COPD,
with evidence of improvements in exercise capacity, health-
related quality of life and dyspnoea.16 The effect size is considered
to be greater than that of bronchodilator drugs.1,17 There is also
evidence for reductions in length of hospital admissions.18
Rehabilitation should be considered at all stages of COPD when
symptoms or disability is present (usually Medical Research
Council dyspnoea grade 3).
The latest National Institute of Clinical Excellence COPD
guidelines recommend a stepwise approach to COPD manage-
ment including medication and a range of non-pharmacological
interventions.1
The problem
GPs in the east London borough of Tower Hamlets serve a
population of 260,000, of whom more than 50% are from ethnic
minority groups, with 30% being south Asian. This population is
one of the top three most socially deprived localities in England,
and has adult male smoking rates of 24% compared with 20% for
the whole of England.19 In 2012 a total of 3,466 people in the
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borough had a GP-recorded diagnosis of COPD (crude prevalence
1.23%, prevalence age standardised to the European standard
population 2.2%).20
In 2008, Tower Hamlets was one of the top three localities in
England for emergency COPD hospital admissions.21 At the time,
there was little evidence of integrated care along the COPD
pathway with no provision for hospital admission avoidance and
poor provision of community-based pulmonary rehabilitation. The
quality of primary care for COPD was suboptimal, with lower than
expected rates of diagnosis and low take-up of regular care
planning reviews and non-pharmacological interventions.
Recent evidence suggests that delivery of optimal, evidence-
based interventions in ambulatory settings can prevent complica-
tions, reduce exacerbation rates, reduce time to recovery
and reduce deterioration in the quality of life.15 In turn it is
thought that these measures may prevent unnecessary hospital
admission.1,22 It remains uncertain which model of ambulatory
care translates into best outcomes, although there is evidence to
suggest that health gain is greatest when the investment is in
primary care settings.23
This project evaluates a locality-wide quality improvement
project that involved all general practices in the area. Networks
made up of four to ﬁve practices (population size 25–40,000) were
tasked with collectively delivering an agreed care package for
COPD. The aim of the package was to achieve measurable
changes in clinically important indicators of COPD management
between 2010 and 2013.
Key measures for improvement
A number of care package key performance indicators (KPIs) were
chosen to assess the impact on COPD care in the locality. The
focus of the care package was on COPD case ﬁnding, and ensuring
that all patients, including the housebound, had a structured
review and care plan annually or bi-annually depending on the
severity of disease. The following indicators were ﬁnancially
incentivised at network level.
1. An increase in the number of COPD cases on network registers
(10% in the ﬁrst year).
2. An increase in the number of care plans completed in the
previous 15 months, with a target of 80%. Housebound
patients were separately targeted.
3. Increased referrals to community-based pulmonary rehabilita-
tion, with a target of 75% among those with an MRC dyspnoea
scale of 3 or more.1
Annual inﬂuenza immunisation among people with a range of
chronic conditions is already ﬁnancially incentivised in the QOF.
This indicator was included as a quality marker for the package,
but did not receive further ﬁnancial incentive, and no target was
set for performance.
Smoking cessation, and referral for treatment, is similarly
incentivised in the QOF, and hence was not included as a
targeted KPI in the care package. However, the high prevalence of
smoking in inner east London as a whole, and the high persistent
smoking rates among people with COPD, is a continuing concern.
Smoking prevalence and the record of stop smoking attempts
were routinely monitored as part of the care package metrics.
We also tracked rates of emergency hospital admission for
COPD among Tower Hamlets residents.
MATERIALS AND METHODS
In 2008 Tower Hamlets became a pilot site for a borough-wide integrated
care programme.24 Tower Hamlets PCT chose to invest in the development
of GP networks across the 36 GP practices to improve the out-of-hospital
care for a range of chronic diseases.25–27 Eight geographically clustered
networks, each consisting of 4–5 neighbouring practices, were developed
to deliver four chronic disease care packages of which COPD was one. The
COPD care package, including all patients with spirometry values indicative
of COPD, was phased in for all networks between April and June 2010.
The care package general practice activity and costings were developed
by a group of local hospital and community clinicians supported by project
management from a management consultancy ﬁrm. The content of the
care package reﬂected National Institute of Clinical Excellence guidance.1
Clinical targets were set pragmatically, with the aim of extending the
performance of clinical teams, but remaining achievable. The content of
the care package focused on regular patient review and care planning for
all, including the housebound. Using structured data entry templates for
these reviews encouraged a systematic approach to monitoring the
disease and co-morbidities such as depression and osteoporosis, reviewing
medicine use, and encouraging the take-up of non-pharmacological
interventions. Network coordinators provided a systematic approach to
recall and management of non-attenders.
A further investment was in information technology (IT) required to
provide real-time tracking of the KPIs for each of the care packages. As part
of the set-up costs, each of the eight networks had funding for a network
manager and recall coordinator to work across all care packages. All
networks had training in organisational change and development.
Network funding to deliver the COPD care package (approximately
£300,000 across all networks per annum) was provided as 70% upfront
running costs based on COPD register size and severity, and 30% at the
end of the year for achieving the care package targets collectively as a
network (this was reduced proportionately according to the distance from
the target for some networks). Each network had autonomy on the use and
distribution of funds to achieve the KPI targets. Most developed a COPD
team to provide local leadership and build practice engagement. Specialist
support from the community respiratory team provided spirometry
training to practices, community-based pulmonary rehabilitation and a
hospital admission avoidance service. This involved a same-day home
assessment and review service by respiratory nurse specialists. Provision of
this additional expert home support (including prescription of nebulisers
and medication as required) was designed to improve patient and GP
conﬁdence in managing more patients outside the hospital. The
components of the network intervention are summarised in Figure 1.
The decision to fund networks rather than individual practices
encouraged a process of peer scrutiny, and required the collective
management of the ﬁnancial resource. Network boards reviewed practice
performance against targets, and the clinical leads worked with practice
teams to support delivery and share best practice.
The introduction of a quarterly community COPD multidisciplinary team
meeting (MDT), led by a respiratory consultant, provided educational
support to all primary care clinicians, with discussion time for recent
advances or guidelines, and complex cases (see Figure 2).
Network intervention summary
Package delivery by practice nurses, HCAs and GPs
Uniform activity recording using templates on practice computers 
CRT for admission
avoidance and
complex care at
home
List cleansing, case finding and staff training
Quarterly MDTs support case
management
network forums to share ideas
Employment of network managers
and recall co-ordinators to support
multiple care packages
Advance funding to networks (70%)
(30% retained for performance)
overall costs approx £300,000
Network COPD leads
support practice COPD
teams to organise
practice delivery
Network boards review performance
of constituent practices, monitor
progress and suggest changes
PCT provides monthly dashboard to
track progress of care package
delivery
Figure 1. Flow chart to show summary of network intervention. CRT,
community respiratory team; GP, general practitioner; HCA, health-
care assistant; MDT, multidisciplinary team; PCT, primary care trust.
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Information sources
We used EMIS Web (http://www.emis-online.com/emis-web) to collect
demographics (age, sex, social deprivation and ethnicity) and routinely
collected clinical COPD management data from all 36 general practices in
Tower Hamlets, and similar data from two neighbouring primary care trusts
(PCTs) to enable local comparisons. Hospital Episode Statistics (HES) data for
COPD-related emergency hospital admissions for Tower Hamlets resident
population were accessed from the Tower Hamlets commissioning support
unit. These are collated for the whole population in ﬁnancial years (April to
March). Admission data for London and England up to 2010 were obtained
from HES e-atlas (http://www.apho.org.uk/). All hospital admission rates were
age standardised to the European standard population. Information on
pulmonary rehabilitation and community respiratory team activity came from
the Barts Health NHS Trust. Costs associated with network set-up and care
package funding came from Tower Hamlets PCT.
The UK-wide Quality and Outcomes Framework was used for national
comparisons of performance.8 All data were obtained from the Quality and
Outcomes Framework online database, and all comparisons between localities
were made without any reported exceptions.28 All QOF outcome data are
crude counts of register size, and performance against a range of clinical
targets collated at the end of the ﬁnancial year for individual practices and for
primary care organisations. Hence, the 2010 data refer to data collected on 31
March 2010 and reﬂect clinical activity during 2009–2010.
Data analysis
We used STATA version 1029 for all data analysis.
Comparative data for the eight networks were taken from the monthly
dashboards, which are populated from EMIS Web searches. Small
differences between data from the dashboard ﬁgures and those from
the annual QOF returns occur because only COPD patients with recorded
spirometry values are included in the care package. Values of each target
for Tower Hamlets were compared annually with surrounding localities, the
whole of London and England using the QOF online database.
RESULTS
Changes to the three care package KPIs that were ﬁnancially
incentivised are considered ﬁrst.
COPD register growth (target 10% for 2012 and 5% for 2013)
Improvement in the identiﬁcation of people with COPD was a
central aim for the network intervention. The observed prevalence
of COPD is thought to be well below the predicted prevalence,
with the gap between observed and expected prevalence
estimated to be 2.1% for England.30 Tower Hamlets has a larger
gap between observed and predicted prevalence at 2.4%,
reﬂecting the lower rate of diagnostic identiﬁcation and recording.
The COPD register increase, summed across all networks,
reached the care package target of 10% for 2012 and exceeded
the 5% target for 2013 (see Table 1). Overall, between 2010 and
Multi disciplinary team meetings–the consultant’s perspective
Including MDTs as part of the COPD care package was crucial. We tend to work in silos and
getting together with primary care and community colleagues to discuss COPD, and individual
patients, has been enlightening. First, I think we all understand our own services better, and
the challenges faced when looking after complicated patients: from pulmonary rehabilitation
( don’t call it that to patients’), to oxygen assessments ( ear lobe blood gases’) and the
complexities and magic of the GP computer systems (  What does it say on EMIS?’). I did not
realise how much of the work in primary care is done by the practice nurses and how important
their hard work is. The probing of my knowledge during sessions has been good for me, I now
make sure I have read up on every new guideline or study, because I am sure someone will ask
about it. Certain issues have come up that we may not have thought about much before,
such as fitness to fly assessments, lung transplantation and early palliative care involvement.
The focus on the care package metrics (and payments), and the sharing of best practice to deal
with them, has given the meetings a powerful direction. Most importantly, the patient
discussions have been insightful. By thinking about one patient in detail, we worked out that
frequent admissions were due to undiagnosed early dementia and her forgotten prednisolone.
Concern that we had failed another patient because they were admitted was rightly challenged
when we learned that they never let the community team into their house!
Finally, I have discovered parts of east London only previously viewed on an electronic map, and
appreciate much better the communities and GP surgeries that we serve.
’ ’
’
Figure 2. Multidisciplinary team meetings—the consultant’s per-
spective. COPD, chronic obstructive pulmonary disease; MDT,
multidisciplinary team.
Table 1. Achievement, by network, 2010–2013 for care package metrics
N1 N2 N3 N4 N5 N6 N7 N8 Tower Hamlets PCT Care package target
Network population size
July 2010 38,744 37,383 25,442 29,575 26,784 28,018 37,824 35,301 259,071
March 2012 41,300 40,451 28,103 31,810 28,758 31,696 40,595 40,645 283,358
March 2013 39,795 40,660 27,738 32,315 28,368 33,275 40,131 39,836 282,118
COPD register size
July 2010 420 405 210 376 399 220 507 261 2,798 Baseline
March 2012 454 448 220 432 451 287 583 301 3,176a 10% Growth
March 2013 479 481 239 457 487 310 617 321 3,391b 5% Growth
% With annual review and self-management plan
July 2010 51.1 61 38.4 58.2 57 58.7 49.3 46 53.2 Baseline
March 2012 79.7 81 89.1 84.2 86 75.3 80.2 87.3 84.2 80%
March 2013 77 83 92.5 89.3 87.5 90 88 88.9 86.5 80%
% With MRC ⩾ 3 referred to pulmonary rehabilitation
July 2010 47.6 41.1 33.3 52.6 49 52.3 41.8 45.4 45.6 Baseline
March 2012 60.8 61.3 40.6 58.8 57.4 89.6 55.7 56 60.1 75%
March 2013 68.5 69.6 71.5 77.9 70.7 82.7 59 75.2 70.7 75%
% With annual ﬂu immunisation
July 2010 85.2 84.9 84.8 79.5 80.2 82.7 86.2 85.4 83.6
March 2012 89.1 86.4 87.3 81.3 84 82.6 81.8 85.7 84.4
March 2013 86.2 84.4 84.5 84 83 84.2 84.1 83.2 84.2
N1–8= eight general practitioner networks, each consisting of four or ﬁve geographically adjacent practices.
Abbreviations: COPD, chronic obstructive pulmonary disease; PCT, primary care trust.
a10% Increase in COPD register size.
b7% Increase in COPD register size
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2013, register size increased by 21%. Networks used a variety of
approaches to achieve this metric, including recalling smokers
within target age groups (435 years) for spirometry, reviewing
the diagnosis of asthma among persistent smokers, and including
brief questionnaires for COPD in new patient registration checks.
Care plans completed
Annual review and care planning for people with COPD involves a
collaborative consultation based on shared decision making and
support for self-management, including referral to pulmonary
rehabilitation and smoking cessation services. The proportion of
people with a completed annual review rose from 53% at the start
of the intervention to 86.5% in 2013 (see Table 1).
Figure 3 compares the annual QOF ﬁgures for Tower Hamlets
with those for England for this metric. This shows sustained
improvement between 2011 and 2013, the higher rates in Tower
Hamlets being signiﬁcantly different from England rates.
Pulmonary rehabilitation referral
The proportion of patients with an MRC dyspnoea scale value of
3 or more referred to pulmonary rehabilitation increased from
45% in 2010 to 70% across all the networks at the end of March
2013 (see Table 1). There is no national benchmark to use as a
comparison for this metric.
The care package tracked other indicators including ﬂu
immunisation, smoking rates among people with COPD and
hospital admissions.
Rates of annual ﬂu immunisation for patients with COPD were
already high in comparison with London and England in 2009,
prior to the introduction of the practice networks. The rate of
immunisation shows steady improvement, and for 2012 was
signiﬁcantly higher than the rate for England (see Table 1 and
Figure 4). Sustaining this improved performance may be linked to
the network infrastructure that supports patient recall and annual
reviews. Although smoking cessation was a central component of
the annual review, we were not able to show changes in smoking
persistence among patients with COPD. At the start of the care
package, 39% were still smokers; in 2013 this value was 40.4%.
Hospital admissions
Emergency COPD hospital admissions for all Tower Hamlets
residents were tracked during the introduction of the care
package. Historic high levels of emergency COPD admissions
have fallen, although rates remain higher than the London
average (see Figure 5). The introduction of an outreach team for
admission avoidance may have contributed to further decline
since 2011. The annual activity of this team for the year to March
2012 included 120 patients referred by GPs for admission
avoidance. Of them, 24 required hospital admission within 28 days
of referral.
DISCUSSION
Main ﬁndings
The network intervention introduced a combination of ﬁnancial
and organisational investment into geographical clusters of
general practices. Behaviour change included IT-driven perfor-
mance feedback, alongside educational facilitation and ﬁnancial
performance incentives at the network level.
Our results show that all eight networks achieved improve-
ments in the identiﬁcation of COPD cases within the practice
population and for COPD care processes over the 3-year period.
We also show that Tower Hamlets PCT achieved improvements in
QOF indicators in comparison with England.
The targets for the care package were designed to challenge
performance by the networks and to encourage network
clinical leaders to work towards integrating essential community
respiratory services into the care pathway. We report on hospital
admissions, and note that the local rate for emergency COPD
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Figure 3. Chronic obstructive pulmonary disease (COPD) patients
with a completed annual review. Tower Hamlets compared with
England (95% conﬁdence intervals). Data are from Quality and
Outcomes Framework with no exception reporting (http://www.
gpcontract.co.uk). This indicator was introduced in 2010.
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Figure 4. Rates of annual inﬂuenza immunisation for chronic
obstructive pulmonary disease (COPD) patients. Tower Hamlets
compared with England (95% conﬁdence intervals). Data are from
Quality and Outcomes Framework with no exception reporting
(http://www.gpcontract.co.uk).
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Figure 5. Chronic obstructive pulmonary disease (COPD) admis-
sions, rates per 100,000 population, in Tower Hamlets 2007–2011
compared with London and England. Age standardised to the
European Union population. Hospital admission data for London
and England from e-HES atlas. Tower Hamlets data from e-HES and
Tower Hamlets Commissioning Support Unit.
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admission (which was among the highest in London) is reducing
towards London and national rates. We speculate that improve-
ments to preventive activity and exacerbation management may
contribute to these results, alongside the work of admission
avoidance by the community respiratory team. National admission
rates for COPD show wide variations by primary care organisations
(PCOs) and by practice, and are associated with COPD prevalence,
social deprivation and higher population smoking rates.31
However, we are aware that at present there is no current UK
evidence to link improvement in practice-based disease
management with changes in COPD admission rates, and
the observed results for Tower Hamlets may equally reﬂect
changes to hospital practice or methods of coding hospital
admissions.
Smoking prevalence remains high in Tower Hamlets, and there
is a paucity of evidence on which stop smoking interventions work
best with socially disadvantaged populations.32 Our analysis
shows that on average 40% of COPD patients continue to smoke.
Similar ﬁgures were found in Salford.33
Commissioning an adequate capacity of community-based
pulmonary rehabilitation, in geographic locations spread through-
out the borough, formed part of the integrated care pathway for
COPD. However, even when there is good local provision,
engagement of patients remains a challenge. Data from a
London-wide collaboration on COPD11 suggest a 30% drop-out
rate between referral and ﬁrst attendance for assessment. Figures
for Tower Hamlets showed high rates of referral into the service
(70% of patients) but we report a similar rate of 35% for attrition
between referral and ﬁrst attendance.
Findings in relation to previously published work
Integrated care programmes aim to improve clinical outcomes
and patient experience by developing a range of organisational
and clinical integration across primary, community and hospital
settings.34–36 Programmes also aim to shift care from expensive
acute hospitals to cheaper primary and community service
settings for those conditions best managed out of hospital.24
The programme organisational structure can take a variety of
forms, and there is little consensus on which structures best
achieve, and sustain, the desired changes.37,38 Evidence from
other out-of-hospital quality improvement schemes for COPD
in the UK is scarce. Some London boroughs have introduced
local pay for performance schemes, which have increased the
prevalence of recognised COPD.39 Finding the ‘missing millions’40
is particularly important in London where the gap between
observed and predicted prevalence is the widest. The Finnish
10-year national programme for COPD effected positive changes
in the process of diagnosis and care, and a reduction in the
number of hospital episodes was also noted.22
Strengths and limitations of the study
This evaluation beneﬁts from the inclusion of all practices, and
hence all patients with a diagnosis of COPD, in the study area.
Engagement with the intervention, and performance as measured
by the quantitative metrics, varied between networks, reﬂecting
differences in the prior organisation and capacity of the
constituent practices and differences between patients in the
areas served. We found that a key factor for success was
the engagement of clinicians, both in the planning, implementa-
tion and governance of the programme and in contributing to the
educational support seen in the MDT meetings. However, the
unique contribution in this initiative has been the ﬁnancial
investment in a practice network structure, alongside investment
in an IT backbone to support the development of real-time
information on clinical performance, which has high face validity
for both clinicians and commissioners. Devolving resource and
responsibility to groups of local providers enabled the practices to
ﬁnd collective local solutions to deal systematically with the
complexities and fragmentation of existing care pathways.41
The decision to fund networks rather than individual practices
encouraged a process of peer scrutiny and collective management
of the ﬁnancial resource. Network boards reviewed practice
performance against targets and the clinical leads worked with
practice teams to support delivery. The introduction of a quarterly
community COPD MDT meeting, led by a respiratory consultant,
provided ongoing education to all primary care clinicians, with
discussion time set aside for analysis of key performance indicators,
recent advances in treatment and individual discussion of difﬁcult
cases. The consultant also provided rapid access to advice by e-mail
or telephone. These elements provided an alternative source of
clinical support to reduce the need for outpatient referral.
The design of this quality improvement programme has
important limitations. Practices were not randomised to the
intervention, and other factors may have affected primary care
management of COPD during the period of the intervention.
Hence, uncertainty remains about the relationship between
the intervention and the observed outcomes. Despite these
limitations, routinely available data make essential contributions
to the evaluation of system change programmes introduced
pragmatically by commissioning organisations.
Implications for future research, policy and practice
For the future, there is a review of the care packages on a yearly
basis. Targets are reviewed and stretched if necessary, or dropped
in favour of others. We hope to develop greater input from
patients to determine whether they consider the process of COPD
care to have been enhanced as a result of the network care
packages.
Conclusions
Improvements in COPD primary care in a socially deprived,
ethnically diverse locality were observed over a 3-year period
following ﬁnancial and organisational investment into general
practice networks.
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